|
|
|
Volumn 23, Issue 6, 1996, Pages 737-743
|
|
Adjuvant application of interferons
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BCG VACCINE;
BETA INTERFERON;
GANGLIOSIDE GM2;
INTERFERON;
CANCER IMMUNOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
DRUG MEGADOSE;
FLU LIKE SYNDROME;
HIGH RISK PATIENT;
HUMAN;
IMMUNOMODULATION;
MAJOR CLINICAL STUDY;
MELANOMA;
PRIORITY JOURNAL;
REVIEW;
TREATMENT PLANNING;
ADJUVANTS, IMMUNOLOGIC;
ANTINEOPLASTIC AGENTS;
CANCER VACCINES;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
DRUG COMBINATIONS;
FEMALE;
G(M2) GANGLIOSIDE;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
INTERFERON-GAMMA, RECOMBINANT;
INTERLEUKIN-2;
MALE;
MELANOMA;
MULTICENTER STUDIES;
NEOPLASM STAGING;
SKIN NEOPLASMS;
VACCINES, CONJUGATE;
|
|
EID: 0030473428
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
